Isabella Orienti Selected Research

Isabella Orienti Research Topics

13	Neoplasms (Cancer) 03/2024 - 07/2014
9	Neuroblastoma 02/2023 - 06/2006
2	Residual Neoplasm 02/2023 - 01/2019
1	Disease Progression 10/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2021
1	COVID-19 05/2020
1	Infections 05/2020
1	Obesity 05/2020
1	Severe Acute Respiratory Syndrome 05/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2015
1	Lung Neoplasms (Lung Cancer) 07/2014
1	Experimental Melanoma 08/2007
1	Melanoma (Melanoma, Malignant) 06/2006

12	FenretinideIBA 03/2024 - 02/2012
3	Antineoplastic Agents (Antineoplastics)IBA 08/2019 - 06/2006
2	RetinoidsIBA 03/2024 - 07/2014
2	AntibodiesIBA 02/2023 - 01/2020
2	Lenalidomide (CC 5013)FDA Link 01/2020 - 01/2019
2	AlbuminsIBA 02/2015 - 07/2014
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2024
1	AntigensIBA 02/2023
1	naxitamab-gqgkIBA 02/2023
1	CarbohydratesIBA 02/2023
1	PolyaminesIBA 06/2022
1	SpermidineIBA 06/2022
1	Mutant Proteins (Protein, Mutant)IBA 10/2021
1	Antiviral Agents (Antivirals)IBA 05/2020
1	VaccinesIBA 05/2020
1	MicellesIBA 01/2019
1	AminesIBA 11/2016
1	NanocapsulesIBA 02/2015
1	Human Serum Albumin FDA LinkGeneric 07/2014
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 08/2007
1	Transferrin Receptors (Transferrin Receptor)IBA 08/2007
1	IronIBA 08/2007
1	CaspasesIBA 06/2006

4	Drug Therapy (Chemotherapy) 02/2023 - 06/2006
3	Therapeutics 05/2020 - 01/2019
2	Oral Administration 03/2024 - 11/2016
2	Aftercare (After-Treatment) 02/2023 - 08/2012
2	Intravenous Administration 02/2015 - 02/2012
1	Immunotherapy 02/2023
1	Lasers (Laser) 01/2020
1	Chemoprevention 01/2019